Interstitial cystitis/painful bladder syndrome

American Family Physician

Volumn 83, Issue 10, 2011, Pages 1175-1181

  French, Linda M ^a   Bhambore, Neelam ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UC Davis Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMITRIPTYLINE; BCG VACCINE; BENZODIAZEPINE DERIVATIVE; CHONDROITIN SULFATE; CIMETIDINE; CYCLOSPORIN A; DIMETHYL SULFOXIDE; DOXYCYCLINE; HYALURONIC ACID; HYDROXYZINE EMBONATE; MUSCLE RELAXANT AGENT; NARCOTIC AGENT; OXYBUTYNIN; PENTOSAN POLYSULFATE; PHENAZOPYRIDINE; PLACEBO; QUERCETIN; RESINIFERATOXIN;

ANESTHETIC BLADDER CHALLENGE; ARTICLE; BEDTIME DOSAGE; CLINICAL FEATURE; CYSTECTOMY; CYSTOSCOPY; DIFFERENTIAL DIAGNOSIS; DRUG APPROVAL; DRUG EFFICACY; HUMAN; INTERSTITIAL CYSTITIS; INTRAVESICAL POTASSIUM SENSITIVITY TEST; LABORATORY DIAGNOSIS; NERVE STIMULATION; NOCTURIA; PAIN; PATHOGENESIS; PELVIC EXAMINATION; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PUDENDAL NERVE; PUDENDAL NERVE STIMULATION; QUESTIONNAIRE; SACRAL NERVE STIMULATION; SCORING SYSTEM; SCREENING TEST; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; URINALYSIS; URINARY DIVERSION; URINE CULTURE;

EID: 79956338972     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Clemens JQ, Joyce GF, Wise M, Payne CK. Interstitial cystitis/painful bladder syndrome. In: Litwin MS, Saigal CS, eds. Urologic Diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Printing Office; 2007. NIH Publication No. 07-5512:125-156.
2. Parsons CL. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology. 2007;69(4 suppl):9-16.
3. Parsons CL. Prostatitis, interstitial cystitis, chronic pelvic pain, and urethral syndrome share a common pathophysiology: lower urinary dysfunctional epithelium and potassium recycling. Urology. 2003;62(6):976-982.
4. Hurst RE, Moldwin RM, Mulholland SG. Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis. Urology. 2007;69(4 suppl):17-23.
5. Parsons CL, Greene RA, Chung M, Stanford EJ, Singh G. Abnormal urinary potassium metabolism in patients with interstitial cystitis. J Urol. 2005;173(4):1182-1185.
6. Sant GR, Kempuraj D, Marchand JE, Theoharides TC. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology. 2007;69(4 suppl):34-40.
7. Theoharides TC, Kempuraj D, Sant GR. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology. 2001;57(6 suppl 1):47-55.
8. Etiology, pathogenesis, and diagnosis of interstitial cystitis. Rev Urol. 2002;4 suppl 1:S9-S15.
9. Parsons CL. Diagnosing chronic pelvic pain of bladder origin. J Reprod Med. 2004;49(3 suppl):235-242.
10. Evans RJ, Sant GR. Current diagnosis of interstitial cystitis: an evolving paradigm. Urology. 2007;69(4 suppl):64-72.
11. van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60-67.
12. O'Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology. 1997;49(5A suppl):58-63.
13. Rosenberg MT, Hazzard M. Prevalence of interstitial cystitis symptoms in women: a population based study in the primary care office. J Urol. 2005;174(6):2231-2234.
14. Parsons CL, Dell J, Stanford EJ, et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology. 2002;60(4):573-578.
15. Parsons CL, Albo M. Intravesical potassium sensitivity in patients with prostatitis. J Urol. 2002;168(3):1054-1057.
16. Kelada E, Jones A. Interstitial cystitis. Arch Gynecol Obstet. 2007;275(4):223-229.
17. Hanno P. Is the potassium sensitivity test a valid and useful test for the diagnosis of interstitial cystitis? Against. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16(6):428-429.
18. Parsons CL, Rosenberg MT, Sassani P, Ebrahimi K, Koziol JA, Zupkas P. Quantifying symptoms in men with interstitial cystitis/prostatitis, and its correlation with potassium-sensitivity testing. BJU Int. 2005;95(1):86-90.
19. Parsons CL. Potassium sensitivity test. Tech Urol. 1996;2(3):171-173.
20. Parsons CL. Argument for the use of the potassium sensitivity test in the diagnosis of interstitial cystitis. For. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16(6):430-431.
21. Parsons CL, Stein PC, Bidair M, Lebow D. Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn. 1994;13(5):515-520.
22. CL. Interstitial cystitis and lower urinary tract symptoms in males and females-the combined role of potassium and epithelial dysfunction. Rev Urol. 2002;4 suppl 1:S49-S55.
23. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol. 1988;140(1):203-206.
24. Nickel JC. Interstitial cystitis: the paradigm shifts: international consultations on interstitial cystitis. Rev Urol. 2004;6(4):200-202.
25. Moldwin RM, Evans RJ, Stanford EJ, Rosenberg MT. Rational approaches to the treatment of patients with interstitial cystitis. Urology. 2007;69(4 suppl):73-81.
26. van Ophoven A, Pokupic S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172(2):533-536.
27. Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int. 2001;87(3):207-212.
28. Sairanen J, Tammela TL, Leppilahti M, et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol. 2005;174(6):2235-2238.
29. Dawson TE, Jamison J. Intravesical treatments for painful bladder syndrome/interstitial cystitis. Cochrane Database Syst Rev. 2007;(4):CD006113.
30. Davis EL, El Khoudary SR, Talbott EO, Davis J, Regan LJ. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol. 2008;179(1):177-185.
31. Riedl CR, Engelhardt PF, Daha KL, Morakis N, Pflüger H. Hyaluronan treatment of interstitial cystitis/painful bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(5):717-721.
32. Peters KM, Feber KM, Bennett RC. A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis. BJU Int. 2007;100(4):835-839.
33. Shorter B, Lesser M, Moldwin RM, Kushner L. Effect of comestibles on symptoms of interstitial cystitis. J Urol. 2007;178(1):145-152.
34. Theoharides TC, Kempuraj D, Vakali S, Sant GR. Treatment of refractory interstitial cystitis/painful bladder syndrome with CystoProtek-an oral multi-agent natural supplement. Can J Urol. 2008;15(6):4410-4414.
35. Theoharides TC, Sant GR. A pilot open label study of Cystoprotek in interstitial cystitis. Int J Immunopathol Pharmacol. 2005;18(1):183-188.
36. Yong SM, Dublin N, Pickard R, Cody DJ, Neal DE, N'Dow J. Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev. 2003;(1):CD003306.